|
56
|
256
|
2od3B |
Human thrombin chimera with human residues 184a, 186, 186a, 186b, 186c and 222 replaced by murine thrombin equivalents. |
|
60
|
258
|
2jh0D |
Human thrombin hirugen inhibitor complex |
|
1
|
28
|
2jh5C |
Human thrombin hirugen inhibitor complex |
|
2
|
28
|
2jh0C |
Human thrombin hirugen inhibitor complex |
|
58
|
258
|
2jh6D |
Human thrombin hirugen inhibitor complex |
|
56
|
258
|
2jh5D |
Human thrombin hirugen inhibitor complex |
|
1
|
28
|
2jh6C |
Human thrombin hirugen inhibitor complex |
|
3
|
27
|
2hwlA |
Crystal structure of thrombin in complex with fibrinogen gamma' peptide |
|
53
|
257
|
2hpqH |
Structures of the noncovalent complexes of human and bovine prothrombin fragment 2 with human ppack-thrombin |
|
4
|
30
|
2hpqL |
Structures of the noncovalent complexes of human and bovine prothrombin fragment 2 with human ppack-thrombin |
|
55
|
259
|
2hgtH |
Structure of the hirugen and hirulog 1 complexes of alpha-thrombin |
|
55
|
257
|
2hwlB |
Crystal structure of thrombin in complex with fibrinogen gamma' peptide |
|
13
|
79
|
2hppP |
Structures of the noncovalent complexes of human and bovine prothrombin fragment 2 with human ppack-thrombin |
|
2
|
30
|
2hppL |
Structures of the noncovalent complexes of human and bovine prothrombin fragment 2 with human ppack-thrombin |
|
15
|
100
|
2hntF |
Crystallographic structure of human gamma-thrombin |
|
51
|
257
|
2hppH |
Structures of the noncovalent complexes of human and bovine prothrombin fragment 2 with human ppack-thrombin |
|
7
|
79
|
2hpqP |
Structures of the noncovalent complexes of human and bovine prothrombin fragment 2 with human ppack-thrombin |
|
1
|
67
|
2hntE |
Crystallographic structure of human gamma-thrombin |
|
3
|
33
|
2hgtL |
Structure of the hirugen and hirulog 1 complexes of alpha-thrombin |
|
2
|
28
|
2hntL |
Crystallographic structure of human gamma-thrombin |
|
5
|
67
|
2hntC |
Crystallographic structure of human gamma-thrombin |
|
57
|
259
|
2h9tH |
Crystal structure of human alpha-thrombin in complex with suramin |
|
2
|
28
|
2h9tL |
Crystal structure of human alpha-thrombin in complex with suramin |
|
54
|
257
|
2gp9B |
Crystal structure of the slow form of thrombin in a self-inhibited conformation |
|
3
|
32
|
2gp9A |
Crystal structure of the slow form of thrombin in a self-inhibited conformation |
|
1
|
27
|
2gdeL |
Thrombin in complex with inhibitor |
|
58
|
256
|
2gdeH |
Thrombin in complex with inhibitor |
|
51
|
257
|
2feqH |
Orally active thrombin inhibitors |
|
3
|
31
|
2fesL |
Orally active thrombin inhibitors |
|
3
|
28
|
2feqL |
Orally active thrombin inhibitors |
|
54
|
257
|
2fesH |
Orally active thrombin inhibitors |
|
2
|
28
|
2cf8L |
Complex of recombinant human thrombin with an inhibitor |
|
1
|
28
|
2cn0L |
Complex of recombinant human thrombin with a designed inhibitor |
|
2
|
28
|
2cf9L |
Complex of recombinant human thrombin with an inhibitor |
|
61
|
257
|
2cf8H |
Complex of recombinant human thrombin with an inhibitor |
|
2
|
29
|
2c8yA |
Thrombin inhibitors |
|
57
|
257
|
2cf9H |
Complex of recombinant human thrombin with an inhibitor |
|
59
|
259
|
2c90B |
Thrombin inhibitors |
|
62
|
259
|
2c8zB |
Thrombin inhibitors |
|
4
|
29
|
2c8xA |
Thrombin inhibitors |
|
60
|
259
|
2c8xB |
Thrombin inhibitors |
|
60
|
257
|
2cn0H |
Complex of recombinant human thrombin with a designed inhibitor |
|
58
|
259
|
2c8wB |
Thrombin inhibitors |
|
59
|
259
|
2c8yB |
Thrombin inhibitors |
|
4
|
29
|
2c8wA |
Thrombin inhibitors |
|
59
|
257
|
2bxtH |
Design and discovery of novel, potent thrombin inhibitors with a solubilizing cationic p1-p2-linker |
|
59
|
259
|
2c93B |
Thrombin inhibitors |
|
2
|
29
|
2c93A |
Thrombin inhibitors |
|
1
|
27
|
2bxtL |
Design and discovery of novel, potent thrombin inhibitors with a solubilizing cationic p1-p2-linker |
|
4
|
29
|
2c90A |
Thrombin inhibitors |
